ArriVent BioPharma, Inc. Common Stock

AVBP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$74,293$150,389$163,372$37,280
Short-Term Investments$144,570$0$0$0
Receivables$500$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$7,616$9,579$19,250$5,672
Total Curr. Assets$226,979$159,968$182,622$42,952
Property Plant & Equip (Net)$154$291$139$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$47,683$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$126$2,839$72$87
Total NC Assets$47,963$3,130$211$87
Other Assets$0$0$0$0
Total Assets$274,942$163,098$182,833$43,039
Liabilities
Payables$3,782$4,532$3,094$293
Short-Term Debt$162$140$128$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$13,330$6,952$5,138$1,525
Total Curr. Liab.$17,274$11,624$8,360$1,818
LT Debt$14$177$11$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$14$177$11$0
Other Liabilities$0$0$0$0
Cap. Leases$176$317$139$0
Total Liabilities$17,288$11,801$8,371$1,818
Equity
Pref Stock$0$304,490$259,571$89,865
Common Stock$3$0$0$0
Retained Earnings-$238,333-$157,845-$88,512-$51,606
AOCI-$211$0$0-$2
Other Equity$496,195$4,652$3,403$2,964
Total Equity$257,654$151,297$174,462$41,221
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$274,942$163,098$182,833$43,039
Net Debt-$74,117-$150,072-$163,233-$37,280
ArriVent BioPharma, Inc. Common Stock (AVBP) Financial Statements & Key Stats | AlphaPilot